New diabetes drug aims to beat insulin in blood sugar control
NCT ID NCT06688123
First seen Nov 24, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This study compares a new medicine called SHR-3167 to insulin glargine in people with type 2 diabetes who are not yet on insulin. Participants take either drug alongside their current metformin or SGLT2 inhibitor pills. The main goal is to see which treatment better lowers blood sugar levels over 20 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jiangsu Provincial People's Hospital
Nanjing, Jiangsu, 210029, China
-
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, 200233, China
Conditions
Explore the condition pages connected to this study.